| 時間 | 講題 | 講師 | 座長 |
| 13:00 | Opening Remarks | 李文領 理事長 | |
| Topic 1: High bleeding risk and choice of stents What is the preferred stent in patients suffering from ACS with high bleeding risk ? |
|||
| 13:05 | Bio-degradable polymer drug-eluting stents | 李政翰 | 方慶章 |
| 13:20 | Durable polymer drug-eluting stents | 施志遠 | |
| 13:35 | Drug coating balloon | 王宇澄 | |
| 13:50 | Rebuttal (each 3 mins) | ||
| 14:00 | Vote | ||
| 14:05 | Special Lecture: Updated anti-thrombotic therapy and choice of P2Y12 inhibitor in Eat-Asia ACS patients with high bleeding risk | 劉秉彥 | 李文領 |
| 14:25 | Coffee Break | ||
| Topic 2: Long-term pharmacological management of chronic coronary syndrome What is the preferred pharmacological therapy for high ischemic/low bleeding risk CAD in long-term? |
|||
| 14:35 | Standard DAPT and then long-term P2Y12 inhibitor | 方修御 | 郭風裕 |
| 14:50 | Extended DAPT (>30 months) | 黃成偉 | |
| 15:05 | Low dose Xa-inhibitor on top of aspirin after standard DAPT | 陳郁志 | |
| 15:20 | Rebuttal (each 3 mins) | ||
| 15:30 | Vote | ||
| Topic 3: What is the preferred SINGLE anti-platelet therapy for post-PCI patient beyond period of DAPT? | |||
| 15:35 | Clopidogrel | 李俊偉 | 盧澤民 |
| 15:50 | Ticagrelor | 李任光 | |
| 16:05 | Prasugrel | 朱俊源 | |
| 16:20 | Rebuttal (each 3 minutes) | ||
| 16:30 | Vote | ||
| Topic 4: Long-term pharmacological management for our CAD patients with type 2 DM ? Which one is the BEST choice for CAD/DM patients in long-term outcomes as add-on therapy? |
|||
| 16:35 | SGLT2 inhibitor | 賴志泓 | 王光德 |
| 16:50 | GLP1 receptor agonist | 鄧欣一 | |
| 17:05 | Rebuttal (each 3 mins) | ||
| 17:12 | Vote | ||
| 17:15 | Closing Remarks | 洪大川 主委 | |
HOME
聯絡我們
Language